|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 3111954 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16163440.7 |
| Date of filing the European patent application | 2011-11-04 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation | 2019-07-10 |
| (30) | Number | Date | Country code |
| 410533 P | 2010-11-05 | US |
| (72) |
MPOFU, Shepard, CH
RICHARDS, Hanno, CH
THANGAVELU, Karthinathan, CH
MACHACEK, Matthias, CH
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ankilozuojančio spondilito gydymo būdai, naudojant anti-IL-17 antikūnus |
| METHODS OF TREATING ANKYLOSING SPONDYLITIS USING ANTI-IL-17 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2023-10-19 | 13 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-11-07 |